Floyd F. Petersen net worth and biography

Floyd Petersen Biography and Net Worth

Floyd F. Petersen, M.P.H. has served as a member of our Board of Directors since August 2004. From 1986 to the present, Mr. Petersen has been an Assistant Professor of Biostatistics at Loma Linda University Schools of Public Health, Medicine, and Nursing. From 1990 to 2010, he served as Director of the Loma Linda University Health Research Consulting Group, which consults on health research study design and data analysis. He has personally consulted on over 700 health-related research projects. As a visiting professor, he has taught/consulted in health research in Chad, Romania, PR China, Thailand, Cambodia, PDR Lao, Kenya, Indonesia, Guam, and Russia. Mr. Petersen was a member of the Loma Linda, California City Council from 1990 to 2010 and served as the Mayor of Loma Linda from 1996 to 2006. Mr. Petersen is currently the vice-chair and a board member of Vtrans, a non-profit, quasi-governmental agency, which coordinates all public transportation for the elderly and handicapped in the Inland Empire of Southern California. He earned his M.P.H. in Public Health from Loma Linda University with concentrations in Biostatistics and Health Administration.

What is Floyd F. Petersen's net worth?: The estimated net worth of Floyd F. Petersen is at least $2.88 million as of September 5th, 2024. Mr. Petersen owns 75,409 shares of Amphastar Pharmaceuticals stock worth more than $2,875,345 as of December 26th. This net worth approximation does not reflect any other investments that Mr. Petersen may own. Learn More about Floyd F. Petersen's net worth.
How do I contact Floyd F. Petersen?: The corporate mailing address for Mr. Petersen and other Amphastar Pharmaceuticals executives is 11570 SIXTH STREET, RANCHO CUCAMONGA CA, 91730. Amphastar Pharmaceuticals can also be reached via phone at (909) 980-9484 and via email at [email protected]. Learn More on Floyd F. Petersen's contact information.
Has Floyd F. Petersen been buying or selling shares of Amphastar Pharmaceuticals?: Floyd F. Petersen has not been actively trading shares of Amphastar Pharmaceuticals during the past quarter. Most recently, Floyd F. Petersen sold 3,000 shares of the business's stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $46.47, for a transaction totalling $139,410.00. Following the completion of the sale, the director now directly owns 75,409 shares of the company's stock, valued at $3,504,256.23. Learn More on Floyd F. Petersen's trading history.
Who are Amphastar Pharmaceuticals' active insiders?: Amphastar Pharmaceuticals' insider roster includes Diane Gerst (Director), Richard Koo (Director), Howard Lee (Director), Yakob Liawatidewi (EVP), Mary Luo (COO), Ziping Luo (Chairman), William Peters (CFO), Floyd Petersen (Director), Richard Prins (Director), Michael Zasloff (Director), Jack Zhang (CEO), Yongfeng Zhang (Co-Founder), and Rong Zhou (EVP). Learn More on Amphastar Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Amphastar Pharmaceuticals?: In the last year, insiders at the sold shares 21 times. They sold a total of 363,042 shares worth more than $19,564,696.71. The most recent insider tranaction occured on December, 12th when EVP Rong Zhou sold 7,000 shares worth more than $310,940.00. Insiders at Amphastar Pharmaceuticals own 27.1% of the company. Learn More about insider trades at Amphastar Pharmaceuticals.
Information on this page was last updated on 12/12/2024.

Floyd F. Petersen Insider Trading History at Amphastar Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/5/2024	Sell	3,000	$46.47	$139,410.00	75,409
6/10/2024	Sell	3,000	$41.40	$124,200.00	78,409
6/3/2024	Sell	500	$42.65	$21,325.00	78,333
5/1/2024	Sell	500	$41.67	$20,835.00	78,833
4/1/2024	Sell	500	$43.43	$21,715.00	79,333
3/1/2024	Sell	500	$45.69	$22,845.00	79,833
2/1/2024	Sell	500	$53.10	$26,550.00	80,333
1/2/2024	Sell	500	$61.37	$30,685.00	80,833
12/1/2023	Sell	500	$57.90	$28,950.00	81,333
11/1/2023	Sell	500	$45.30	$22,650.00	81,833
10/2/2023	Sell	500	$45.78	$22,890.00	82,333
5/17/2023	Sell	5,000	$43.13	$215,650.00	80,117
4/3/2023	Sell	491	$37.72	$18,520.52	85,117
3/1/2023	Sell	500	$36.70	$18,350.00	85,608
2/1/2023	Sell	500	$30.35	$15,175.00	86,108
12/1/2022	Sell	500	$30.13	$15,065.00	87,108
10/3/2022	Sell	500	$28.59	$14,295.00	88,108
8/1/2022	Sell	500	$37.48	$18,740.00	89,108
7/1/2022	Sell	500	$34.78	$17,390.00	89,608
6/1/2022	Sell	500	$37.00	$18,500.00	85,945
5/18/2022	Sell	9,924	$35.05	$347,836.20	86,445
5/2/2022	Sell	295	$35.18	$10,378.10	76,078
4/1/2022	Sell	500	$36.69	$18,345.00	76,373
3/1/2022	Sell	500	$27.27	$13,635.00
2/1/2022	Sell	500	$24.08	$12,040.00
1/3/2022	Sell	500	$23.22	$11,610.00
12/22/2021	Sell	1,000	$22.50	$22,500.00
6/3/2021	Sell	10,000	$18.65	$186,500.00	83,354
2/1/2021	Sell	639	$18.26	$11,668.14	73,354
12/1/2020	Sell	500	$17.87	$8,935.00	73,993
11/2/2020	Sell	500	$19.84	$9,920.00	74,493
9/1/2020	Sell	500	$19.90	$9,950.00	75,493
8/3/2020	Sell	500	$20.62	$10,310.00	75,993
7/1/2020	Sell	500	$22.27	$11,135.00	76,493
6/1/2020	Sell	500	$18.97	$9,485.00	71,142
5/1/2020	Sell	500	$16.66	$8,330.00	71,642
4/1/2020	Sell	500	$14.36	$7,180.00	72,142
1/2/2020	Sell	1,000	$19.14	$19,140.00	73,642
12/2/2019	Sell	500	$19.25	$9,625.00	74,642
11/1/2019	Sell	500	$19.48	$9,740.00	75,142
10/1/2019	Sell	500	$19.92	$9,960.00	75,642
9/16/2019	Sell	500	$21.75	$10,875.00	76,142
10/4/2017	Sell	39,312	$18.59	$730,810.08
1/3/2017	Sell	400	$18.61	$7,444.00	58,717
12/1/2016	Sell	400	$20.26	$8,104.00	59,117
10/3/2016	Sell	400	$18.75	$7,500.00	59,917
9/8/2016	Sell	3,000	$19.05	$57,150.00	60,317
8/15/2014	Buy	3,200	$10.35	$33,120.00

Floyd F. Petersen Buying and Selling Activity at Amphastar Pharmaceuticals

Amphastar Pharmaceuticals Company Overview

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Today's Range

Now: $38.13

$37.81

$38.60

50 Day Range

MA: $46.04

$38.27

$53.40

2 Week Range

Now: $38.13

$36.56

$65.92

Volume

100,190 shs

Average Volume

414,062 shs

Market Capitalization

$1.83 billion

P/E Ratio

12.71

Dividend Yield

N/A

Beta

0.78

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol